Lotus Eye Hospital and Institute Limited has informed the Exchange about Action(s) taken or orders passed
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Lotus Eye Hospital has informed the exchanges that BSE and NSE each levied a fine of Rs.2,17,120 (inclusive of GST), totalling about Rs.4.34 lakh, for non-compliance with Regulation 17(1A) of SEBI (LODR) Regulations, 2015. Regulation 17(1A) typically pertains to board composition requirements (such as appointment of non-executive directors or directors exceeding 75 years of age requiring shareholder approval). The order was communicated on February 27, 2026, and pertains to the quarter ended December 31, 2025. The company clarified that the non-compliance has already been rectified through shareholder approval via Postal Ballot on January 17, 2026, and that prior fines up to the September 2025 quarter were duly paid. The company stated there is no material financial or operational impact.
The fine is small in monetary terms and the company states no material impact on finances or operations. However, this is a recurring penalty for the same non-compliance, which may raise minor governance concerns for shareholders monitoring board composition and compliance track record.